Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 179,883 | 309,507 | 163,289 | 404,841 | -- |
| General And Administrative Expense | 172,445 | 226,934 | 112,955 | 335,234 | -- |
| Other Operating Expenses | 88,637 | 102,492 | 104,310 | 80,607 | -- |
| Operating Expense | 268,520 | 411,999 | 267,599 | 485,448 | -- |
| Operating Income | -268,520 | -411,999 | -267,599 | -485,448 | -- |
| EBIT | -265,395 | -299,500 | -370,752 | -255,878 | -- |
| Interest Expense | 1,212 | 1,326 | 1,835 | 1,988 | -- |
| Interest Expense Non Operating | 1,212 | 1,326 | 1,835 | 1,988 | -- |
| Interest Income | 4,099 | 4,871 | 0.00 | -- | 137.00 |
| Interest Income Non Operating | 4,099 | 4,871 | 0.00 | -- | 137.00 |
| Net Interest Income | 2,887 | 3,545 | -1,835 | -1,988 | -- |
| Other Income Expense | -974.00 | 107,628 | -103,153 | 229,570 | -- |
| Other Non Operating Income Expenses | 17,120 | 97,810 | 4,480 | 257,070 | -- |
| Special Income Charges | -- | 0.00 | -38,314 | 0.00 | 81,663 |
| Restructuring And Mergern Acquisition | -- | -- | -- | -190,000 | -81,663 |
| Gain On Sale Of Security | -18,094 | 9,818 | -69,319 | -27,500 | -- |
| Pretax Income | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Income From Continuing Operation Net Minority Interest | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Income Including Noncontrolling Interests | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Income Common Stockholders | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Income | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| EBITDA | -265,395 | -299,500 | -370,752 | -255,878 | -- |
| Normalized EBITDA | -247,301 | -309,318 | -263,119 | -228,378 | -- |
| Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Basic Average Shares | 40.6M | 37.1M | 30.9M | 26.9M | -- |
| Diluted Average Shares | 40.6M | 37.1M | 30.9M | 26.9M | -- |
| Total Unusual Items | -18,094 | 9,818 | -107,633 | -27,500 | -- |
| Total Unusual Items Excluding Goodwill | -18,094 | 9,818 | -107,633 | -27,500 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -248,513 | -310,644 | -264,954 | -230,366 | -- |
| Diluted NI Availto Com Stockholders | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Impairment Of Capital Assets | -- | 0.00 | 38,314 | 0.00 | -- |
| Insurance And Claims | 10,745 | 10,000 | 9,166 | 0.00 | -- |
| Net Income Continuous Operations | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Non Operating Interest Income Expense | 2,887 | 3,545 | -1,835 | -1,988 | -- |
| Other Gand A | 123,766 | 113,274 | 103,789 | 102,299 | -- |
| Salaries And Wages | 37,934 | 103,660 | 0.00 | 232,935 | -- |
| Selling And Marketing Expense | 7,438 | 82,573 | 50,334 | 69,607 | -- |
| Total Expenses | 268,520 | 411,999 | 267,599 | 485,448 | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 46,434 | 95,524 | 182,663 | 459,489 | -- |
| Cash Cash Equivalents And Short Term Investments | 46,434 | 150,524 | 227,663 | 574,489 | -- |
| Cash Financial | -- | -- | -- | 459,489 | 378,347 |
| Other Short Term Investments | 0.00 | 55,000 | 45,000 | 115,000 | -- |
| Accounts Receivable | 6,514 | 2,130 | 3,799 | 13,563 | -- |
| Receivables | 6,514 | 2,130 | 3,799 | 13,563 | -- |
| Prepaid Assets | 900.00 | 1,162 | 22,834 | 0.00 | -- |
| Current Assets | 53,848 | 153,816 | 254,296 | 588,052 | -- |
| Gross PPE | 1.2M | 1.1M | 753,120 | -- | -- |
| Accumulated Depreciation | -6,091 | -2,610 | 0.00 | -- | -- |
| Net PPE | 1.2M | 1.1M | 753,120 | 707,049 | -- |
| Total Non Current Assets | 1.3M | 1.2M | 808,120 | 762,049 | -- |
| Total Assets | 1.4M | 1.3M | 1.1M | 1.4M | -- |
| Accounts Payable | 149,579 | 66,233 | 61,566 | 60,449 | -- |
| Payables | 149,579 | 66,233 | 61,566 | 60,449 | -- |
| Payables And Accrued Expenses | 149,579 | 66,233 | 61,566 | 60,449 | -- |
| Other Current Liabilities | 3,320 | 440.00 | -- | 4,480 | -- |
| Current Liabilities | 152,899 | 66,673 | 61,566 | 64,929 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 152,899 | 66,673 | 61,566 | 64,929 | -- |
| Common Stock | 3.0M | 2.9M | 2.4M | 2.1M | -- |
| Capital Stock | 3.0M | 2.9M | 2.4M | 2.1M | -- |
| Retained Earnings | -2.3M | -2.1M | -1.8M | -1.4M | -- |
| Gains Losses Not Affecting Retained Earnings | 542,816 | 480,868 | 364,703 | 407,357 | -- |
| Common Stock Equity | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Stockholders Equity | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Total Equity Gross Minority Interest | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Total Capitalization | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Net Tangible Assets | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Tangible Book Value | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Working Capital | -99,051 | 87,143 | 192,730 | 523,123 | -- |
| Invested Capital | 1.2M | 1.3M | 1.0M | 1.3M | -- |
| Share Issued | 42.5M | 38.3M | 30.9M | 29.3M | -- |
| Ordinary Shares Number | 42.5M | 38.3M | 30.9M | 29.3M | -- |
| Non Current Prepaid Assets | 59,805 | 57,139 | 55,000 | 55,000 | -- |
| Other Equity Interest | -- | -- | -- | 132,720 | -- |
| Other Properties | 1.2M | 1.1M | 753,120 | -- | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -171,180 | -272,753 | -276,204 | -256,682 | -- |
| Cash Flow From Continuing Operating Activities | -171,180 | -272,753 | -276,204 | -256,682 | -- |
| Stock Based Compensation | 37,934 | 103,660 | 0.00 | 232,935 | -- |
| Change In Working Capital | 56,338 | 32,223 | -7,451 | -2,181 | -- |
| Change In Receivables | -4,384 | 1,669 | 9,764 | -12,002 | -- |
| Change In Payables And Accrued Expense | 60,460 | 8,882 | 5,619 | 9,821 | -- |
| Other Non Cash Items | -17,120 | -97,810 | -4,480 | -257,070 | -- |
| Capital Expenditure | -- | -34,803 | -- | -- | -25,000 |
| Purchase Of PPE | 0.00 | -34,803 | 0.00 | 0.00 | -- |
| Net PPE Purchase And Sale | 0.00 | -34,803 | 0.00 | 0.00 | -- |
| Sale Of Investment | 36,725 | 0.00 | -- | 0.00 | 41,602 |
| Net Investment Purchase And Sale | 36,725 | 0.00 | -- | 0.00 | 41,602 |
| Investing Cash Flow | -56,392 | -372,172 | -88,185 | -313,445 | -- |
| Cash Flow From Continuing Investing Activities | -56,392 | -372,172 | -88,185 | -313,445 | -- |
| Issuance Of Capital Stock | 178,587 | 558,689 | 0.00 | 442,780 | -- |
| Net Common Stock Issuance | 178,587 | 558,689 | 0.00 | 442,780 | -- |
| Financing Cash Flow | 178,587 | 558,689 | 88,265 | 651,269 | -- |
| Cash Flow From Continuing Financing Activities | 178,587 | 558,689 | 88,265 | 651,269 | -- |
| Effect Of Exchange Rate Changes | -105.00 | -903.00 | -702.00 | 0.00 | -- |
| Changes In Cash | -48,985 | -86,236 | -276,124 | 81,142 | -- |
| Beginning Cash Position | 95,524 | 182,663 | 459,489 | 378,347 | -- |
| End Cash Position | 46,434 | 95,524 | 182,663 | 459,489 | -- |
| Free Cash Flow | -171,180 | -307,556 | -276,204 | -256,682 | -- |
| Asset Impairment Charge | -- | 0.00 | 38,314 | 0.00 | -- |
| Change In Prepaid Assets | 262.00 | 21,672 | -22,834 | 0.00 | -- |
| Common Stock Issuance | 178,587 | 558,689 | 0.00 | 442,780 | -- |
| Gain Loss On Investment Securities | 18,275 | -10,000 | -- | -162,500 | -80,765 |
| Net Income From Continuing Operations | -266,607 | -300,826 | -372,587 | -257,866 | -- |
| Net Investment Properties Purchase And Sale | -- | -- | 0.00 | 125,000 | 100,000 |
| Net Other Financing Charges | -- | -- | -- | -- | 50,000 |
| Net Other Investing Changes | -93,117 | -337,369 | -88,185 | -438,445 | -- |
| Operating Gains Losses | 18,275 | -10,000 | -- | -162,500 | -80,765 |
| Proceeds From Stock Option Exercised | -- | 0.00 | 88,265 | 208,489 | 50,000 |
| Sale Of Investment Properties | -- | -- | 0.00 | 125,000 | 100,000 |
| Sale Of PPE | -- | -- | -- | -- | 72,248 |
| Unrealized Gain Loss On Investment Securities | -- | -10,000 | 70,000 | 27,500 | -- |